S-1: CirTran Files S-1 for $10M Equity Offering Amid Losses

CirTran Corporation filed an S-1 registration statement for the resale of up to 1,731,509 shares of common stock by a selling stockholder, potentially raising up to $10 million for working capital and debt repayment.

Summary

• CirTran Corporation, an international manufacturing, distribution, and marketing company, primarily deals in licensed consumer products including tobacco and HUSTLER-branded beverages.
• The company entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. on December 19, 2025, allowing it to sell up to $10,000,000 of common stock at its discretion over a 24-month period.
• Up to 1,731,509 shares of common stock are being registered for resale by the Selling Stockholder, representing approximately 26% of outstanding shares as of the prospectus date, with potential for further dilution if more shares are issued to reach the $10M commitment.
• Proceeds from sales to the Selling Stockholder will be used for working capital and general corporate purposes, with 50% specifically allocated to repay existing secured indebtedness to Tekfine, LLC.
• The company reported a net loss of $2,626,876 for the year ended December 31, 2024, and a net loss of $1,138,064 for the nine months ended September 30, 2025.
• As of September 30, 2025, CirTran had an accumulated deficit of $62.8 million and a working capital deficiency of $22.9 million.
• The company's auditors have issued a going concern qualification for its financial statements, indicating substantial doubt about its ability to continue operations without additional capital.
• All of CirTran's assets are encumbered to secure approximately $4 million in indebtedness and accrued interest on secured convertible debentures, with payments beginning in April 2027 if not converted.

Sentiment

Score: 2

Explanation: The company is in severe financial distress, evidenced by a history of significant losses, a large accumulated deficit, and a substantial working capital deficiency. The going concern qualification from auditors and the encumbrance of all assets by debt are critical negative indicators. While the potential $10M equity raise offers a lifeline, it comes with significant dilution risk and does not guarantee long-term stability given the underlying financial challenges and operational losses.

Positives

• Net sales for the three months ended September 30, 2025, increased by 75.1% to $448,492, up from $256,070 in the prior-year period, driven by higher sales in the vapor product line.
• Net loss from continuing operations decreased by $455,064 for the three months ended September 30, 2025, to $406,208, compared to $861,272 in the prior-year period.
• Net loss from continuing operations decreased by $650,654 for the nine months ended September 30, 2025, to $1,048,292, compared to $1,698,946 in the prior-year period.
• Selling, general, and administrative expenses decreased by 7.8% for the three months ended September 30, 2025, and by 10% for the nine months ended September 30, 2025, due to reduced marketing and promotions spending.
• The company has the potential to raise up to $10 million in gross proceeds through the Standby Equity Purchase Agreement, which could provide much-needed capital.

Negatives

• The company reported a net loss of $2,626,876 for the year ended December 31, 2024, and $1,138,064 for the nine months ended September 30, 2025.
• An accumulated deficit of $61.6 million as of December 31, 2024, and $62.8 million as of September 30, 2025, highlights a history of significant losses.
• A working capital deficiency of $21,839,245 as of December 31, 2024, and $22,897,132 as of September 30, 2025, indicates severe liquidity issues.
• The auditors' report includes a going concern qualification, raising substantial doubt about the company's ability to continue operations.
• All company assets are encumbered to secure approximately $4 million in indebtedness and accrued interest on secured convertible debentures.
• The potential issuance of up to 1,731,509 shares (or more) to the Selling Stockholder poses a substantial dilution risk to existing stockholders.
• The company's common stock is a 'penny stock' (trading below $5.00 per share), which imposes additional sales practice requirements on broker-dealers and may limit liquidity.
• Revenue decreased by 19.8% to $1,296,796 for the year ended December 31, 2024, compared to $1,616,148 in 2023.
• Gross profit decreased to $838,638 in 2024 from $1,006,497 in 2023, and to $533,062 for the nine months ended September 30, 2025, from $619,419 in the prior-year period.
• Operating activities used $1,031,790 of net cash during the nine months ended September 30, 2025.

Risks

• The company may be deemed insolvent and face liquidation, as it is unable to meet all obligations and liabilities may exceed assets.
• The auditors' report contains a qualification about the company's ability to continue as a going concern, indicating substantial doubt.
• All assets are encumbered to secure approximately $4 million of indebtedness and accrued interest on secured convertible debentures, risking asset execution upon default.
• International business operations are susceptible to adverse effects from changes in tariffs and other governmental actions impacting trade.
• Distribution of tobacco products may lead to increased regulation, sales restrictions, or litigation.
• The company requires substantial additional capital from external sources, which may be difficult to obtain due to its precarious financial condition and secured indebtedness.
• Issuance of additional equity securities will dilute the economic and voting interests of existing stockholders.
• Substantial increases in business activities will require skilled management of growth, which the company may struggle to achieve effectively.
• Penny stock regulations may restrict resales of securities, limiting liquidity and potentially causing investors to lose part or all of their investment.
• The company's performance is substantially dependent on the continued services of its President, CEO, and Chairman, Iehab J. Hawatmeh, whose loss would have a substantial adverse effect.

Future Outlook

The company anticipates requiring substantial additional funds from external sources to implement product commercialization and contract manufacturing plans. It expects to use any proceeds from the current equity offering for working capital, general corporate purposes, and debt repayment. Management continues to focus on generating revenue and reducing monthly business expenses through cost reductions and operational streamlining. The ability to obtain future financing on acceptable terms is uncertain due to the company's precarious financial condition and substantial secured indebtedness.

Management Comments

• Management believes that the regulatory climate for tobacco products has stabilized, but cannot assure against additional sales restrictions or litigation.
• Management believes that the facilities described are generally in good condition, well maintained, and suitable and adequate for current needs.
• Management has determined that the probability of realizing any loss on various asserted legal claims from vendors and service providers is remote and will seek to compromise and settle at a deep discount.

Industry Context

CirTran operates in the consumer products industry, specifically manufacturing, marketing, and distributing licensed products like tobacco and beverages. The company leverages its global distribution and manufacturing relationships, particularly in Asia, to support its contract manufacturing and brand commercialization efforts. The industry faces challenges from international trade tariffs and evolving regulations, especially for tobacco products. The trend towards outsourcing manufacturing is seen as a benefit, allowing OEMs to reduce time-to-market and capital investments.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• A judgment of $6.6 million was awarded to Playboy Enterprises, Inc. against Play Beverages and CirTran Beverage Corp. in October 2016, affirmed in September 2018. The company recognized a gain of $18,878,359 in 2023 from discontinued operations due to this debt becoming time-barred.
• The company has delinquent payroll taxes, interest, and penalties with the IRS, including a $500,000 settlement in November 2004 and a $768,526 installment agreement in June 2013. The company is in communication with the IRS regarding the statute of limitations on the 2013 settlement.

Related Party Transactions

• A 10% promissory note for $300,000 was issued in 2007 to a family member of the president, with $151,833 principal outstanding as of September 30, 2025, and no demand for payment made.
• Promissory notes totaling $315,000 (received $300,000) were issued on March 31, 2008, to a family member of the president and two other shareholders, with $72,466 principal outstanding as of September 30, 2025, and no demand for payment made.
• The company owed its president $433,379 in unsecured advances as of September 30, 2025, included in liabilities from discontinued operations, with borrowing fees waived.
• The CEO is owed $7,059 for short-term, non-interest-bearing advances due on demand as of September 30, 2025.
• Net decrease in deposits with a related-party inventory supplier (controlled by the CEO) totaling $1,081,548 during the nine months ended September 30, 2025, resulting in a credit balance of $1,104,000 disclosed as Short-term advances payable related parties.
• Total inventory purchases from the related party were $669,044 and $731,918 during the nine months ended September 30, 2025, and 2024, respectively, at a 2% markup over cost.

Stakeholder Impact

• Shareholders face significant dilution from the potential issuance of up to 1,731,509 shares (or more) to the Selling Stockholder, which could also lead to a decline in stock price volatility.
• Existing stockholders' economic and voting interests will be diluted as their percentage of total outstanding shares decreases.
• Creditors, particularly secured creditors, have encumbrances on all company assets, which could be executed upon default, potentially leaving nothing for other creditors or stockholders.
• Employees and management face uncertainty due to the company's going concern issues and dependence on securing additional capital for continued operations.
• The company's ability to attract new investors may be impaired by its precarious financial condition, substantial secured indebtedness, and penny stock status.

Next Steps

• The registration statement must become effective with the SEC before sales under the Purchase Agreement can commence.
• The company will control the timing and amount of any sales of common stock to the Selling Stockholder, depending on market conditions and funding needs.
• 50% of any proceeds received from the equity offering will be used to repay secured debt to Tekfine, LLC.
• The company expects to access external capital resources in the future to fund any new projects.
• Management will continue efforts to develop product manufacturing relationships, design product logos and labeling, obtain regulatory approvals, and establish distribution channels for HUSTLER-branded products.

Key Dates

Recommendation

CirTran Corporation is in a precarious financial state, marked by a history of substantial net losses, a significant accumulated deficit of over $62 million, and a severe working capital deficiency of nearly $23 million. The auditor's going concern qualification highlights the high risk of business failure. All company assets are encumbered by existing debt, severely limiting financial flexibility and increasing the risk for unsecured creditors and equity holders. While the $10 million standby equity purchase agreement offers a potential capital infusion, it comes with substantial dilution for existing shareholders, and there's no guarantee the full amount will be realized or that it will be sufficient to overcome the deep-seated financial issues. The company's penny stock status further limits liquidity and investor interest. Given the severe financial distress, high operational risks, and significant dilution, a strong sell recommendation is warranted.

Keywords

Standby Equity Purchase Agreement, S-1 Registration, Common Stock, Dilution, Going Concern, Liquidity, Accumulated Deficit, Working Capital Deficiency, Tobacco Products, HUSTLER Brand, Contract Manufacturing, SEC Filing, Financial Distress, Capital Raise, OTC Markets, CIRX